TEHRAN UNIVERSITY OF MEDICAL SCIENCES
🇮🇷Iran
- Country
- 🇮🇷Iran
- Ownership
- Private
- Established
- 1934-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.tums.ac.ir
Effectiveness of the Farsi Diabetes Self-management Education (FDSME) Program for People With Type 2 Diabetes
Not Applicable
Completed
- Conditions
- Type 2 Diabetes Mellitus
- Interventions
- Behavioral: FDSME groupBehavioral: FDSME
- First Posted Date
- 2010-01-15
- Last Posted Date
- 2024-04-10
- Lead Sponsor
- Tehran University of Medical Sciences
- Target Recruit Count
- 280
- Registration Number
- NCT01050803
Omega-3 Fatty Acids and Chemotherapy-induced Neuropathy and Inflammation in Breast Cancer
Phase 4
- Conditions
- Breast Cancer
- Interventions
- Dietary Supplement: oil fishOther: corn oil pearls
- First Posted Date
- 2010-01-14
- Last Posted Date
- 2011-11-01
- Lead Sponsor
- Tehran University of Medical Sciences
- Target Recruit Count
- 52
- Registration Number
- NCT01049295
- Locations
- 🇮🇷
: Tehran University of Medical Sciences, School of Public Health, Tehran, Iran, Islamic Republic of
Zoledronic Acid for the Prevention of Bone Loss Post-bone Marrow Transplantation for Thalassemia Major Patients
Phase 2
- Conditions
- Beta-ThalassemiaBone Marrow Transplantation
- Interventions
- Drug: Placebo
- First Posted Date
- 2009-11-18
- Last Posted Date
- 2011-07-26
- Lead Sponsor
- Tehran University of Medical Sciences
- Target Recruit Count
- 50
- Registration Number
- NCT01016093
- Locations
- 🇮🇷
Hematology-Oncology & SCT Research Center, Tehran, Iran, Islamic Republic of
Prevention Chemotherapy Induced Mucositis by Zinc Sulfate
Phase 2
Completed
- Conditions
- MucositisBone Marrow Transplantation
- Interventions
- Drug: Placebo
- First Posted Date
- 2009-11-18
- Last Posted Date
- 2011-07-26
- Lead Sponsor
- Tehran University of Medical Sciences
- Target Recruit Count
- 60
- Registration Number
- NCT01015183
- Locations
- 🇮🇷
Hematology-Oncology & SCT Research Center, Tehran, Iran, Islamic Republic of
Unrelated Double Umbilical Cord Blood Units Transplantation
Phase 2
- Conditions
- Leukemia, Myeloid, AcuteLeukemia, Lymphoblastic, AcuteLeukemia, Myeloid, Chronic
- Interventions
- Drug: Stem cell Transplantation
- First Posted Date
- 2009-11-18
- Last Posted Date
- 2012-06-04
- Lead Sponsor
- Tehran University of Medical Sciences
- Target Recruit Count
- 10
- Registration Number
- NCT01015742
- Locations
- 🇮🇷
Hematology-Oncology & SCT Research Center, Tehran, Iran, Islamic Republic of
Allogenic Bone Marrow Transplantation (BMT) Compare With Cytoreduction and Chemotherapy in Acute Lymphoblastic Leukemia (ALL) Patients
Phase 2
Completed
- Conditions
- Acute Lymphoblastic Leukemia
- Interventions
- Procedure: ChemotherapyProcedure: Bone Marrow Transplantation
- First Posted Date
- 2009-11-18
- Last Posted Date
- 2010-11-22
- Lead Sponsor
- Tehran University of Medical Sciences
- Target Recruit Count
- 30
- Registration Number
- NCT01015261
- Locations
- 🇮🇷
Hematology-Oncology & SCT Research Center, Tehran, Iran, Islamic Republic of
Autologous Bone Marrow Transplantation (BMT) Compared With Allogeneic BMT in Multiple Myeloma
Phase 2
- Conditions
- Multiple Myeloma
- Interventions
- Procedure: Autologous bone marrow transplantationProcedure: Allogeneic bone marrow transplantation
- First Posted Date
- 2009-10-20
- Last Posted Date
- 2012-06-04
- Lead Sponsor
- Tehran University of Medical Sciences
- Target Recruit Count
- 185
- Registration Number
- NCT00998270
- Locations
- 🇮🇷
Hematology-Oncology & SCT Research Center, Tehran, Iran, Islamic Republic of
Bilateral Transversus Abdominis Plane Block and Postoperative Pain Intensity After Elective Cesarean Delivery
Not Applicable
- Conditions
- Postoperative Pain
- Interventions
- Procedure: TAP blockade
- First Posted Date
- 2009-08-25
- Last Posted Date
- 2010-11-18
- Lead Sponsor
- Tehran University of Medical Sciences
- Target Recruit Count
- 60
- Registration Number
- NCT00964600
- Locations
- 🇮🇷
Sharati hospital, Tehran, Iran, Islamic Republic of
The Study of the Effects of Vitamin A on Immune System in Patients With Atherosclerosis
- First Posted Date
- 2009-08-21
- Last Posted Date
- 2012-06-05
- Lead Sponsor
- Tehran University of Medical Sciences
- Target Recruit Count
- 60
- Registration Number
- NCT00963222
- Locations
- 🇮🇷
Tehran University of Medical Sciences, School of Public Health, Tehran, Iran, Islamic Republic of
Etanercept: Single Blind Control Study in Ocular Manifestations of Behcet's Disease
Not Applicable
- Conditions
- Behcet SyndromeUveal Disease
- Interventions
- First Posted Date
- 2009-07-02
- Last Posted Date
- 2010-11-22
- Lead Sponsor
- Tehran University of Medical Sciences
- Target Recruit Count
- 80
- Registration Number
- NCT00931957
- Locations
- 🇮🇷
Rheumatology Research Center, Behcet's Disease Unit (Shariati Hospital), Tehran, Iran, Islamic Republic of
© Copyright 2025. All Rights Reserved by MedPath